OMNI Kudos to Dickenson CSB for Strong Interview Follow-up Rate

Throughout 2022, we have been sharing some shout-outs about CSBs or Agencies that are doing well with their intakes, follow-ups, engaging and supporting clients, and/or those that demonstrate a "spirit of inquiry" when engaging with our TA Team on GPRA administration issues.

This month, we’d like to highlight Dickenson CSB. As you know, SAMHSA requires an 80% follow-up GPRA rate, and only “interview” follow-up GPRAs count towards this rate. Over the past year, Dickenson has exceeded SAMHSA’s rate in at least three different months (reaching 83%) and have an overall average rate approaching 80%. Their intake GPRA numbers have remained steady, as well. We appreciate the extra effort it takes to encourage clients to participate in the important interview follow-up GPRAs so that we can better learn about the impact that SOR-funded services have over time on clients receiving treatment. May the trend continue!

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.